Polio consultant awarded prestigious Gates Vaccine Innovation Award

The Bill and Melinda Gates Foundation has awarded its prestigious Vaccine Innovation Award to polio consultant Dr Asm Amjad Hossain

Melinda Gates, co-chair of the Bill and Melinda Gates Foundation, meets with Dr Asm Amjad Hossain, the recipient of the first Gates Vaccine Innovation Award Bill and Melinda Gates Foundation

Dr Hossain, originally from Bangladesh and currently based in Nigeria supporting the country’s polio eradication efforts there, received the Award from among 117 nominations encompassing a range of innovative solutions to increase vaccination coverage.

The Award is in direct recognition of Dr Hossain’s innovative work in raising immunization coverage rates in key districts of Bangladesh, by institutionalising processees for registering pregnant women with expected delivery dates, annual schedules for vaccine sessions, and key active community outreach strategies. “(These innovations) show how looking at old problems in new ways can make a profound difference,” said Mr Bill Gates, co-chair of the Bill and Melinda Gates Foundation. “Improvements like these are spreading to other locations because of the commitment and creativity of Dr Hossain and many others like him.”

The Award was established by the Bill and Melinda Gates Foundation to recognize and celebrate revolutionary ways in which children in the poorest parts of the world are immunized. The Award winner is recognized with US$250,000 and personally acknowledged by Gates Foundation leadership.

Related


Related News

   25/10/2022
We are close to making polio the second human disease to be eradicated, but what will it take to finally consign this killer disease to the history books?
   24/10/2022
The Global Polio Eradication Initiative (GPEI) stands tall on the foundation of millions of women’s efforts and voices.
   21/10/2022
Together, we end polio!
   18/10/2022
More than 3000 scientists and health experts from 115 countries urge the world to fully fund eradication strategy following resurgence of disease